Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
5.78
+0.07 (1.23%)
At close: Apr 28, 2026, 4:00 PM EDT
5.70
-0.08 (-1.38%)
After-hours: Apr 28, 2026, 7:08 PM EDT
Passage Bio Employees
Passage Bio had 24 employees as of December 31, 2025. The number of employees decreased by 36 or -60.00% compared to the previous year.
Employees
24
Change (1Y)
-36
Growth (1Y)
-60.00%
Revenue / Employee
n/a
Profits / Employee
-$1,896,750
Market Cap
18.54M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Citius Pharmaceuticals | 23 |
| Quantum BioPharma | 17 |
| Theriva Biologics | 16 |
| NewcelX | 15 |
| Lipocine | 14 |
| Cocrystal Pharma | 10 |
| Genenta Science | 9 |
| Allarity Therapeutics | 8 |
PASG News
- 8 days ago - Passage Bio Reports Updated Interim Data from upliFT-D Trial and Provides Regulatory and Corporate Updates - GlobeNewsWire
- 7 weeks ago - Passage Bio Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Passage Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Recent Business Highlights - GlobeNewsWire
- 2 months ago - Passage Bio Transcript: Oppenheimer 36th Annual Healthcare Life Sciences Conference - Transcripts
- 2 months ago - Passage Bio to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 5 months ago - Passage Bio Transcript: Guggenheim Securities 2nd Annual Healthcare Innovation Conference - Transcripts
- 6 months ago - Passage Bio Reports Third Quarter 2025 Financial Results and Provides Recent Business Highlights - GlobeNewsWire
- 6 months ago - Passage Bio to Present at Guggenheim Securities 2nd Annual Healthcare Innovation Conference - GlobeNewsWire